J C Lindow

Summary

Affiliation: University of Vermont
Country: USA

Publications

  1. pmc Primary vaccination with low dose live dengue 1 virus generates a proinflammatory, multifunctional T cell response in humans
    Janet C Lindow
    Vaccine Testing Center and Unit of Infectious Diseases, Department of Medicine, University of Vermont College of Medicine, Burlington, Vermont, United States of America
    PLoS Negl Trop Dis 6:e1742. 2012
  2. pmc Caught in the act: in vivo development of macrolide resistance to Campylobacter jejuni infection
    J C Lindow
    Vaccine Testing Center, University of Vermont College of Medicine, Department of Medicine, Burlington, VT 05405, USA
    J Clin Microbiol 48:3012-5. 2010
  3. pmc Antibodies in action: role of human opsonins in killing Salmonella enterica serovar Typhi
    Janet C Lindow
    University of Vermont College of Medicine, Department of Medicine, Vaccine Testing Center and Unit of Infectious Diseases, Burlington, VT 05405, USA
    Infect Immun 79:3188-94. 2011
  4. doi request reprint In a randomized, double-blinded, placebo-controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7 x 10(10) colony-forming units
    C E Lyon
    The University of Vermont College of Medicine, Burlington, VT 05405, USA
    Vaccine 28:3602-8. 2010

Collaborators

Detail Information

Publications4

  1. pmc Primary vaccination with low dose live dengue 1 virus generates a proinflammatory, multifunctional T cell response in humans
    Janet C Lindow
    Vaccine Testing Center and Unit of Infectious Diseases, Department of Medicine, University of Vermont College of Medicine, Burlington, Vermont, United States of America
    PLoS Negl Trop Dis 6:e1742. 2012
    ..This work provides an initial framework for defining primary T cell responses to each DENV serotype and will enhance the evaluation of a tetravalent DENV vaccine...
  2. pmc Caught in the act: in vivo development of macrolide resistance to Campylobacter jejuni infection
    J C Lindow
    Vaccine Testing Center, University of Vermont College of Medicine, Department of Medicine, Burlington, VT 05405, USA
    J Clin Microbiol 48:3012-5. 2010
    ..In vivo development of macrolide resistance may be an important contributor to antibiotic resistance in C. jejuni...
  3. pmc Antibodies in action: role of human opsonins in killing Salmonella enterica serovar Typhi
    Janet C Lindow
    University of Vermont College of Medicine, Department of Medicine, Vaccine Testing Center and Unit of Infectious Diseases, Burlington, VT 05405, USA
    Infect Immun 79:3188-94. 2011
    ..Typhi. Future work could lead to improved immunogenicity tests associated with vaccine efficacy and the identification of correlates of protection against typhoid fever...
  4. doi request reprint In a randomized, double-blinded, placebo-controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7 x 10(10) colony-forming units
    C E Lyon
    The University of Vermont College of Medicine, Burlington, VT 05405, USA
    Vaccine 28:3602-8. 2010
    ..Typhi-specific LPS IgG and 83.3-97.4% IgA; 92.1% had a positive S. Typhi LPS ELISPOT. M01ZH09 is safe and immunogenic up to 1.7 x 10(10)CFU. Efficacy testing of this single-dose oral typhoid vaccine is needed...